PRESERVE_2_infographic_22Aug22_revised-1.pdf (229.19 kB)

Infographic - Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2

figure

posted on 2022-09-22, 08:45 authored by Shom Goel, Antoinette R Tan, Hope S Rugo, Philippe Aftimos, Zoran Andric, Andrew Beelen, Jingshan Zhang, John S Yi, Rajesh Malik, Joyce O’Shaughnessy

Trilaciclib prior to gemcitabine plus

carboplatin for metastatic triple-negative

breast cancer: phase III PRESERVE 2 Infographic

History

Usage metrics

Keywords

carboplatin CDK4/6 inhibitor gemcitabine immunotherapy metastatic overall survival patient-reported outcome phase III trilaciclib triple-negative breast cancer

Licence

CC BY-NC-ND 4.0

Infographic - Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2

History

Usage metrics

Categories

Keywords

Licence

Exports